Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

Delayed Data
As of 11:17am ET
 -0.05 / -1.49%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 10.00 and a low estimate of 2.00. The median estimate represents a +51.52% increase from the last price of 3.30.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Hold stock in BioCryst Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.71%
Growthannually -76.46%


Growthquarterly -1.86%
Growthannually -56.45%
Key to the earnings and sales forecast charts.